Page last updated: 2024-11-08

biguanides and Hematologic Diseases

biguanides has been researched along with Hematologic Diseases in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auzepy, P1
Caquet, R1

Reviews

1 review available for biguanides and Hematologic Diseases

ArticleYear
[Severe hypoglycemia due to insulin. Risks and adverse effects of antidiabetic drugs].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Mar-10, Volume: 59, Issue:10

    Topics: Acidosis; Aged; Biguanides; Brain Diseases; Digestive System Diseases; Drug Eruptions; Drug Interact

1983